510(k) Report

510(k) · Cleared

Cleared

Laserex LP1532 Photocoagulator

K972514510(k) TraditionalCleared Oct 3, 199788-day reviewClass II21 CFR 886.4390

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Ellex Medical Pty, Ltd. · HQF Laser, Ophthalmic

Cleared on Oct 3, 1997 after an 88-day review. The FDA summary names its predicate without a number. 30 later devices descend from it.

Decided
Oct 3, 1997
Review
88 days
Class
Class II
Product code
HQF
Recalls
None
Predicates
0

30 later devices descend from it, 1 citing it directly.

Descendants, by year cleared 2005: 1 descendant cleared2009: 3 descendants cleared2010: 3 descendants cleared2011: 2 descendants cleared2013: 3 descendants cleared2008: 1 descendant cleared2015: 2 descendants cleared2019: 3 descendants cleared2012: 3 descendants cleared2016: 1 descendant cleared2023: 1 descendant cleared2017: 3 descendants cleared2022: 1 descendant cleared2025: 1 descendant cleared2024: 1 descendant cleared2018: 1 descendant cleared1995200020052010201520202025
  1. This deviceK972514 Laserex LP1532 PhotocoagulatorEllex Medical Pty, Ltd. · 1997
  2. Descendant · cites it directly · 29 of its ownK043486 Pascal Photocoagulator, Product-Pascal-01Topcon Medical Laser Systems, Inc. · 2005
  3. Descendant · 2 generations on · 23 of its ownK091666 Pascal Photocoagulator, Pascal-USOptimedica Corporation · 2009
  4. Descendant · 3 generations on · 22 of its ownK092621 Pascal Streamline PhotocoagulatorTopcon Medical Laser Systems, Inc. · 2009
  5. Descendant · 2 generations on · 17 of its ownK081744 Pascal Synthesis Delivery SystemOptimedica Corporation · 2008
  6. Descendant · 4 generations on · 16 of its ownK100019 Pascal Streamline PhotocoagulatorOptimedica Corporation · 2010 · Recalled

Showing 5 of 30 descendants. See all descendants

Descendants cleared per year

2005: 12008: 12009: 32010: 32011: 22012: 32013: 32015: 22016: 12017: 32018: 12019: 32022: 12023: 12024: 12025: 1
2005high 3 (2009) · low 0 (2006)2026

Most influential descendants

Showing 5 of 30 · See all
  • K043486Pascal Photocoagulator, Product-Pascal-01Topcon Medical Laser Systems, Inc. · 2005 · cites it directly29descendants
  • K091666Pascal Photocoagulator, Pascal-USOptimedica Corporation · 2009 · 2 generations on23descendants
  • K092621Pascal Streamline PhotocoagulatorTopcon Medical Laser Systems, Inc. · 2009 · 3 generations on22descendants
  • K081744Pascal Synthesis Delivery SystemOptimedica Corporation · 2008 · 2 generations on17descendants
  • K100019Pascal Streamline PhotocoagulatorOptimedica Corporation · 2010 · 4 generations on16descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K972514Laserex LP1532 PhotocoagulatorEllex Medical Pty, Ltd.1997—
+1K043486Pascal Photocoagulator, Product-Pascal-01Topcon Medical Laser Systems, Inc.2005—
+2K091666Pascal Photocoagulator, Pascal-USOptimedica Corporation2009—
+3K092621Pascal Streamline PhotocoagulatorTopcon Medical Laser Systems, Inc.2009—
+2K081744Pascal Synthesis Delivery SystemOptimedica Corporation2008—
+4K100019Pascal Streamline PhotocoagulatorOptimedica Corporation20101

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200510
200810
200930
201030
201120
201230
201330
201520
201610
201730
201810
201930
202210
202310
202410
202510
FIG. 1 — Lineage of K972514, 1997–2025Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in HQF? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new HQF device

  1. #1 K251772 Navilas Laser System 577sl (156691)score 13.6 · 12 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (4)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*—Alcon Ophthalas 532
Named without a submission number
—
*—Alcon Eyelite
Named without a submission number
—
*—Iris Occulite
Named without a submission number
—
*—Nidek Prima
Named without a submission number
—

What descends from it? (30)

See all 30

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K043486Pascal Photocoagulator, Product-Pascal-01Topcon Medical Laser Systems, Inc.200529

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K043486 (Topcon Medical Laser Systems, Inc., 2005) has gone furthest, with 29 descendants of its own.

How does its category compare?

All HQF devices

HQF Laser, Ophthalmic: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · HQF

3in 2025

2007: 42008: 32009: 72010: 22011: 42012: 52013: 62014: 32015: 42016: 32017: 32018: 12019: 42020: 42021: 12022: 72023: 52024: 32025: 32026 (partial year): 2
2007high 7 (2009) · low 1 (2018)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · HQF

264in 2025

2007: 198 days median2008: 28 days median2009: 115 days median2011: 128 days median2012: 179 days median2013: 225 days median2014: 215 days median2015: 295 days median2016: 271 days median2017: 189 days median2019: 107 days median2020: 53 days median2022: 86 days median2023: 155 days median2024: 167 days median2025: 264 days median
2007high 295 (2015) · low 28 (2008)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · HQF

1in 2025

2007: 22008: 12009: 22010: 32011: 52012: 12013: 22014: 42025: 1
2007high 5 (2011) · low 0 (2015)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · HQF

106in 2025

2007: 602008: 342009: 332010: 432011: 262012: 412013: 392014: 582015: 802016: 1082017: 772018: 822019: 662020: 722021: 1002022: 1112023: 922024: 752025: 106
2007high 111 (2022) · low 26 (2011)2025

MAUDE reports naming product code HQF, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20074198260
2008328134
20097115233
20102—343
20114128526
20125179141
20136225239
20143215458
20154295080
201632710108
20173189077
20181—082
20194107066
2020453072
20211—0100
20227860111
20235155092
20243167075
202532641106
20262—0—

What is it indicated for?

The indication for use for this product are; » Retinal Photocoagulation « Photocoagulation for Macular Degeneration « Pan Retinal Photocoagulation ¢ Laser Trabeculoplasty « Endophotocoagulation. A General Description of these Treatments are; The indications for use for this product are: Retinal treatments, including; . Retinal Photocoagulation . Pan Retinal Photocoagulation . Endophotocoagulation These treatments involve the destruction of neovascular…

Read the full statement (207 words)

The indication for use for this product are;

» Retinal Photocoagulation « Photocoagulation for Macular Degeneration

« Pan Retinal Photocoagulation ¢ Laser Trabeculoplasty

« Endophotocoagulation.

A General Description of these Treatments are;

The indications for use for this product are:

Retinal treatments, including;

. Retinal Photocoagulation

. Pan Retinal Photocoagulation

. Endophotocoagulation

These treatments involve the destruction of neovascular complexes, to obliterate areas of microinfarction or

capillary closure.

Retinal Photocoagulation will be carried out using principally the Slittamp Delivery System accessory.

Pan Retinal Photocoagulation will be carried out using either of the Laser Indirect Ophthalmoscope or the

Slitlamp Delivery System accessory.

Endophotocoagulation will be carried out using any one of the three variants of the endoprobe accessories,

namely Straight, Curved or Aspirating Endooccular Probes.

Photocoagulation for Macular Degeneration involves the destruction of leaking vessels in the macular and

paramacular region, and ultimately to produce a chorioretinal adhesion that will resist ongoing vitreoretinal

traction. This treatment will be carried out using the slittamp microscope mounted Slitlamp Delivery System

accessory.

Laser Trabeculoplasty, the photocoagulation of the trabecular meshwork to create apertures and increase

the flow of the aqueous humor in order to treat open-angle-glaucoma. This treatment will be tarried out using

the slittamp microscope mounted Slittamp Delivery System accessory.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K972514: Laserex LP1532 Photocoagulator.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K972514

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026